Bile ductular proliferation and altered leukotriene elimination in thioacetamide-induced fibrosis of rat liver

Journal of Hepatology

Volumn 25, Issue 4, 1996, Pages 547-553

  Müller, Diethard ^a,c   Enderle, Gerd Jürgen ^a,d   Löw, Otto ^a   Dietze, Eberhard ^b   Krell, Herbert ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Inst für Med Mikrobiologie   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Ductular proliferation; Isoproterenol; Leukotriene elimination; Liver fibrosis; Thioacetamide

Indexed keywords

ISOPRENALINE; LEUKOTRIENE C4; LEUKOTRIENE D4; PEPTIDOLEUKOTRIENE; TAUROCHOLIC ACID; THIOACETAMIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BILE FLOW; BILE SECRETION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; ISOLATED LIVER; ISOTOPE LABELING; LIVER FIBROSIS; LIVER PERFUSION; METABOLISM; MICROSCOPY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030273538     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80215-7     Document Type: Article

References (43)

1. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology. 108:1995;145-156.
2. Saperstein LA, Jirtle RL, Farouk M, Thompson HJ, Chung KS, Meyers WC. Transforming growth factor-β1 and mannose 6-phosphate/insulin-like growth factor II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology. 19:1994;412-417.
3. Krell H. Eicosanoids and bile secretion. Watkins JB, Siegers C-P. Biliary excretion of drugs and other chemicals. Progress in Pharmacology and Clinical Pharmacology. 8/4:1991;435-454 G. Fisher, Stuttgart.
4. Samuelsson B, Dahlén SE, Lindgren JÅ, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1987;1171-1176.
5. Keppler D. Leukotrienes: Biosynthesis, transport, inactivation, and analysis. Rev Physiol Biochem Pharmacol. 121:1992;1-30.
6. Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK. The relation of leukotrienes to liver injury. Hepatology. 5:1985;883-891.
7. Tiegs G, Wendel A. Leukotriene-mediated liver injury. Biochem Pharmacol. 37:1988;2569-2573.
8. Keppler D. Leukotrienes in liver pathophysiology. Hepatol Lett. 9:1989;XI-XVI.
9. Wendel A, Tiegs G. Leukotriene D4 mediates galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 36:1987;1867.
10. Enderle G, Delabar U, Krell H. Different pathomechanisms of altered biliary leukotriene C4 elimination in isolated perfused rat livers. Biochem Pharmacol. 3:1995;297-304.
11. Müller D, Dietze E, Dargel R, Krell H. Stimulation of bile flow and inhibition of biliary secretion of taurocholate and leukotriene C4 in thioacetamide-induced liver fibrosis. Z Gastroenterol. 31:1993;16-19. (Suppl 2).
12. Huber M, Kästner S, Schölmerich J, Gerok W, Keppler D. Analysis of cysteinyl leukotrienes in patients with liver cirrhosis and hepatorenal syndrome. Eur J Clin Invest. 19:1989;53-60.
13. Uemura M, Buchholz U, Kojima H, Keppler A, Hafkemeyer P, Fukui H, Tsujii T, Keppler D. Cysteinyl leukotrienes in the urine of patients with liver diseases. Hepatology. 20:1994;804-812.
14. Zimmermann T, Müller A, Machnik G, Franke H, Schubert H, Dargel G. Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje:WIST rats. Z. Versuchstierkd. 30:1987;165-180.
15. Müller A, Machnik G, Zimmermann T, Schubert H. Thioacetamide-induced cirrhosis-like liver lesions in rats - usefulness and reliability of this animal model. Exp Pathol. 34:1988;229-236.
16. Zimmermann T, Gardemann A, Machnik G, Dargel R, Jungermann K. Metabolic and hemodynamic responses of bivascularly perfused rat liver to nerve stimulation, noradrenaline, acetylcholine and glucagon in thioacetamide-induced micronodular cirrhosis. Hepatology. 15:1992;464-470.
17. Hummel L, Barth A, Zimmermann T, Dargel R. Studies on the fatty acid synthesis of the perfused cirrhotic rat liver. Exp Pathol. 25:1984;45-49.
18. Jaeschke H, Krell H, Pfaff E. No increase in biliary permeability in ethinylestradiol-treated rats. Gastroenterology. 85:1983;808-814.
19. Krell H, Jaeschke H, Höke H, Pfaff E. Bile secretion in hemoglobin-free perfused rat liver. Hoppe Seylers Z Physiol Chem. 365:1984;1115-1122.
20. Denzlinger C, Guhlmann A, Scheuber PH, Wilker D, Hammer DK, Keppler D. Metabolism and analysis of cysteinyl leukotrienes in the monkey. J Biol Chem. 261:1986;15601-15606.
21. Struck H, Nagelschmidt M. Hydroxyprolinfraktionen im Blut. J Clin Chem Clin Biochem. 15:1977;625-628.
22. Hahn EG, Martini GA. Diagnostische Parameter der Kollagenbiosynthese. Internist. 21:1980;195-201.
23. Löw O, Gabler U, Müller A, Gabler P, Schubert H, Löw H-Ch, Machnik G. Morphometry of connective tissue in rat livers. Acta Stereol. 13:1994;101-106.
24. Knuchel J, Krähenbühl S, Zimmermann A, Reichen J. Effect of secretion on bile formation in rats with cirrhosis of the liver: structure-function relationship. Gastroenterology. 97:1989;950-957.
25. Kountouras J, McKavanagh S, Burmicky M, Billing BH. The effect of secretin on bile flow and bile acid and bilirubin excretion following relief of prolonged bile duct obstruction in the rat. J Hepatol. 4:1987;198-205.
26. Pinzani M. Hepatic stellate (ITO) cells: expanding roles for liver-specific pericyte. J Hepatol. 22:1995;700-706.
27. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol. 22:1995;28-36. (Suppl).
28. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
29. Krell H, Höke H, Pfaff E. Development of intrahepatic cholestasis by α-naphthylisothiocyanate in rats. Gastroenterology. 82:1982;507-514.
30. Krell H, Fromm H, Larson RE. Increased paracellular permeability in intrahepatic cholestasis induced by Carmustine (BCNU) in rats. Gastroenterology. 101:1991;180-188.
31. Krell H, Trummer E, Fromm H. Paracellular transport of inorganic phosphate into bile in intrahepatic cholestasis. Bronner F, Peterlik M. Cellular calcium and phosphate transport in health and disease. 1988;293-298 Alan R. Liss, New York.
32. Mong S, Wu HL, Scott MO, Lewis MA, Clark MA, Weichman BM, Kinzig CM, Gleason JG, Crooke ST. Molecular heterogeneity of leukotriene receptors: correlation of smooth muscle contraction and radioligand binding in guinea-pig lung. J Pharmacol Exp Ther. 234:1985;316-325.
33. Metters KM, Gareau Y, Lord A, Rochette C, Sawyer N. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung. J Pharmacol Exp Ther. 270:1994;399-406.
34. Wetmore LA, Gerard NP, Herron DK, Bollinger NG, Baker SR, Feldman HA, Drazen JM. Leukotriene receptor on U937 cells: discriminatory responses to leukotrienes C4 and D4. Am J Physiol. 261:1991;L164-L171.
35. Snyder DW, Cho HL, Gilmore J. Endogenously formed leukotriene C4 activates LTC4 receptors in guinea pig tracheal strips. Eur J Pharmacol. 195:1991;209-215.
36. Mattern MR, Mong S, Mong S-M, Bartus JO, Sarau HM, Clark MA, Foley JJ, Crooke ST. Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cells. Biochem J. 265:1990;101-107.
37. Krell H, Dietze E. Hemodynamic and metabolic responses to leukotriene C4 in isolated perfused rat liver. Hepatology. 10:1989;300-305.
38. 2/5-lipoxygenase-mediated leukotriene C4 production. Cell. 69:1992;295-303.
39. Porreca E, Di Febbo C, Reale M, Barbacane R, Mezzetti A, Cuccurullo F, Conti P. Modulation of rat vascular smooth muscle cell (VSMC) proliferation by cysteinyl leukotriene D4: a role for mediation of interleukin 1. Atherosclerosis. 113:1995;11-18.
40. Wu SH, Kelefiotis DP, Lianos EA. Modulatory effects of eicosanoids on mesangial cell growth in response to immune injury. Immunopharmacol. 28:1994;125-136.
41. Beno DW, Mullen J, Davis BH. Lipoxygenase inhibitors block PDGF-induced mitogenesis: a MAPK-independent mechanism that blocks fos and egr. Am J Physiol. 268:1995;C604-C610.
42. Band L, Perez J, Denis M, Ardaillou R. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol. 138:1987;1190-1195.
43. Phan SH, McGarry BM, Loeffler KM, Kunkel SL. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry. 27:1988;2846-2853.